Mesuximid

Bezeichnung:Mesuximid

CAS-Nr77-41-8

Englisch Name:METHSUXIMIDE

CBNumberCB2695398

SummenformelC12H13NO2

Molgewicht203.24

MOL-Datei77-41-8.mol

Synonyma

Mesuximid

Mesuximid physikalisch-chemischer Eigenschaften

Schmelzpunkt	52-53°
Siedepunkt	bp0.1 121-122°
Dichte	1.1255 (rough estimate)
Brechungsindex	1.5440 (estimate)
storage temp.	Refrigerator
Löslichkeit	Chloroform (Slightly), Methanol (Slightly)
Aggregatzustand	Solid
Farbe	White to Off-White
Wasserlöslichkeit	2.8g/L(25 ºC)

Sicherheit

HS Code	2925190100
Giftige Stoffe Daten	77-41-8(Hazardous Substances Data)
Toxizität	LD50 orally in mice: 0.9 g/kg (Marshall, Vallance)

Gefahreninformationscode (GHS)

METHSUXIMIDE Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung
Methsuximide is a succinimide that is converted to N-desmethylmethosuximide, a channel blocker that targets low threshold calcium currents. Methsuximide is a substrate of cytochrome P450 (CYP) isoform 2C19 that, in turn, inhibits CYP2C19-mediated metabolism of biguanides. Methsuximide has been shown to have anticonvulsant properties in clinical trials.
Chemische Eigenschaften
Light Yellow Oil
Originator
Celontin,Parke Davis,US,1957
Verwenden
A calcium channel succinimide antiepileptic drug. Anticonvulsant.
Definition
ChEBI: Methsuximide is an organic molecular entity.
Manufacturing Process
100 g of α-phenyl-α-methylsuccinic acid and 110 g of 40% aqueous methyl amine are heated together at 200 to 250°C until no more distillate is obtained. Upon vacuum distillation of the residue, the N-methyl-α-phenyl-αmethylsuccinimide, of BP 121° to 122°C at 0.1 mm is obtained. After recrystallization from aqueous ethanol, this compound melts at 52° to 53°C.
Trademarks
Celontin (Parke-Davis).
Therapeutic Function
Anticonvulsant
Clinical Use
Although methsuximide is less commonly used, it may be indicated for the control of absence seizures refractory to other drugs. Although it does not precipitate tonic-clonic convulsions, it often is combined with phenytoin or phenobarbital when absence seizures coexist with tonic-clonic symptoms. Much of the efficacy of methsuximide is attributed to its desmethyl metabolite. The half-life of methsuximide is between 2.6 and 4.0 hours, but the half-life for N-desmethylsuximide is 25 hours, causing it to accumulate substantially. Concentrations of greater than 40 g/mL may be associated with toxicity. Methsuximide is considered to be more toxic than ethosuximide.
Einzelnachweise
[1] nicholls, p. j., and orton, t.c. the physiological disposition of 14c-methsuximide in the rat. br.j.pharmacol. 45(1), 48-59 (1972).
[2] chen g, weston j k, bratton a c. anticonvulsant activity and toxicity of phensuximide, methsuximide and ethosuximide[j]. epilepsia, 1963, 4(1‐4): 66-76.
[3] sigler m, strassburg h m, boenigk h e. effective and safe but forgotten: methsuximide in intractable epilepsies in childhood[j]. seizure, 2001, 10(2): 120-124.
[4] wright j d, helsby n a, ward s a. the role of s‐mephenytoin hydroxylase (cyp2c19) in the metabolism of the antimalarial biguanides[j]. british journal of clinical pharmacology, 1995, 39(4): 441-444.
[5] guengerich f p. human cytochrome p450 enzymes[m]//cytochrome p450. springer us, 1995: 473-535.

METHSUXIMIDE Upstream-Materialien And Downstream Produkte

Mesuximid Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

77-41-8, METHSUXIMIDE Verwandte Suche:

Send Inquriy